Our findings suggest that SSB1 alleviates ALI by targeting key inflammatory factors, including IL1B, TNF, and IL6, thereby modulating the NOD-like receptor signaling pathway and restoring pulmonary metabolic homeostasis. Here, IL1B is linked to acute respiratory distress syndrome.